INJEX Pharma and American Healthcare Products have signed an exclusive distribution agreement to market needle-free syringe Injex 30 in the west coast states of US.
According to the agreement, American Healthcare Products will distribute Injex 30 in Washington state, California, Arizona, Nevada and Oregon and the agreement also includes a fixed minimum volume of 20,000 Injex systems in the first year.
American Healthcare Products managing director Richard Lim said with FDA 510K approval for INJEX 30, American Healthcare Products is much convinced about the market opportunities in the dental, diabetes and medical markets.
''INJEX is the painless injection system and a safe alternative to the traditional needle syringe and a solution for needle phobics,'' Lim added.
''It's Time to market - we have the sales and marketing strategy in the exclusive states prepared, the logistics built up and our long term partners and customers integrated.''
Injex Pharma CEO Andy Rosch said together with American Healthcare Products, Injex Pharma has a strong sales and marketing partner, which has been established in the market, experienced and has a first class network of institutions, associations and clinics.''This is fundamental for the sales opportunities and we are looking forward to a successful market entry with our new partner in the US market,'' Rosch added.
